Search Results 861-870 of 17604 for Assay

1. Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation (ReSPECT) - Mayo Clinic

   Positive baseline serum Platelia GM EIA (≥ 0.5) and/or ?-D glucan assay (Fungitell ≥80 picograms \[pg\]/mL or Fujifilm Wako \>11 pg/mL) within 15 days ...

2. Influenza (Flu) Clinical Trials - Mayo Clinic Research

   ... assay) levels in elderly patients. A Study to Expand Understanding of Coronavirus in U.S. Children (Enrolling by Invitation Only) Rochester, MN. The purpose ...

3. Hormone Therapy For Breast Cancer Clinical Trials - Mayo Clinic Research

   The purpose of this study is to recruit 2000 incident cases of primary breast cancer in order to perform laboratory assays to measure frequencies of genetic ...

4. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

   HER2+ disease as determined by a tissue based assay performed at a central laboratory. Participant has rat sarcoma viral oncogene homolog wild-type (RAS WT) ...

5. New vein of research focuses on inducing pancreatic hypothermia to reduce injury associated with mild and severe acute pancreatitis - Mayo Clinic

   ... assays. By documenting any injury to acinar cells, they gauged the effect of hypothermia on signaling pathways initiated by cerulein and GTL . Research ...

6. Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Patients With Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer - Mayo Clinic

   Known tumor/immune cell PD-L1 status by any assay. Adequate organ function including: Cardiac ejection fraction at or above the institutional lower limit of ...

7. Metastatic Melanoma Clinical Trials - Mayo Clinic Research

   The purpose of this study is to validate an internally developed assay for the detection of BRAF V600E mutations in cfDNA from the peripheral blood of patients ...

8. A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) - Mayo Clinic

   Documentation of an NRAS mutation (tumor tissue or blood) prior to first dose of study drug(s) as determined locally with an analytically validated assay in a ...

9. CATALINA-2: A Clinical Study Of TORL-1-23 In Platinum-resistant Ovarian Cancer.

   * Participant's tumor must be positive for CLDN6 expression as defined by the CLDN6 reference laboratory assay. Tumor tissue will be required for submission ...

10. A Study To Assess The Effectiveness And Safety Of Pacritinib In Patients With VEXAS Syndrome (PAXIS) - Mayo Clinic

    Positive Quantiferon (or other interferon gamma release assay) during Screening. Note: patients with indeterminant Quantiferon results may enroll. Known ...